EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.
Ruppert, A-M
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. [electronic resource] - The European respiratory journal Feb 2009 - 436-40 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1399-3003
10.1183/09031936.00162307 doi
Adenocarcinoma--pathology
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Central Nervous System Neoplasms--secondary
Drug Resistance, Neoplasm
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Gefitinib
Humans
Liver Neoplasms--secondary
Lung Neoplasms--pathology
Male
Neoplasm Metastasis
Quinazolines--administration & dosage
Recurrence
Treatment Outcome
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. [electronic resource] - The European respiratory journal Feb 2009 - 436-40 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1399-3003
10.1183/09031936.00162307 doi
Adenocarcinoma--pathology
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Central Nervous System Neoplasms--secondary
Drug Resistance, Neoplasm
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Gefitinib
Humans
Liver Neoplasms--secondary
Lung Neoplasms--pathology
Male
Neoplasm Metastasis
Quinazolines--administration & dosage
Recurrence
Treatment Outcome